This week is the mild to moderate trial readout. Hoping LLM is successful in keeping people out of the hospital for any length of time by stopping the progression of CV19. It would be a huge humanitarian win as well as a huge win for the hospitals that are getting slammed relentlessly and losing significant revenue from normal surgical procedures.
That said this trial readout does not address the use case needed for what is happening in the severe to critical use case mentioned in the referenced Florida posting.
Market Data 
Markets 
AI
